Nano Bridging Molecules SA
Nano Bridging Molecules S.A. ('NBM') is devoted to researching, developing,
manufacturing, and marketing its patented SurfLink® range of advanced medical
implant surface modifications designed to render medical implants biocompatible
with the human body.
The company's technology has been developed over a 12 year period by
a multi-disciplinary team from a number of renowned academic institutions including
the University of Geneva, Ecole Polytechnique Federale de Lausanne, the University
of Zurich and University of Berne. A university spin-off, NBM was incorporated
in 2002, in 2008 it established new laboratories and offices in Canton Vaud,
Switzerland, it currently employs 7 staff and has entered into over 65 contracts
with various research institutions and other external service providers.
NBM's SurfLink® technology revolves around a concept pursuant to
which a number of biological functions can be covalently bound to medical implant
surfaces. The use of this advanced technology in implant operations promises
to achieve :
- increased biocompatibility
- accelerated bone healing
- greatly enhanced implant fixation, and
- increased long term stability
NBM is currently focusing on its second large animal time course study (52
weeks, 24 animals) and a pilot dental clinical trial which is presently being
expanded into a 3 - 5 centre dental clinical trial. The company will embark
upon a C series funding round in Q1 2010. It aims to CE Mark its first dental
implant surface treatment product in Q2 2010 and obtain FDA authorization to
commence US sales in 2011.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.